CuriRx, Inc., a leading contract development and manufacturing organization (CDMO), announced the launch of the Advanced Bioprocessing and Analytical Center. Led by CuriRx's team...
Novavax, Inc., a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that Australia's Therapeutic Goods Administration (TGA)...
